Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Dyslipidemia

  Free Subscription


Articles published in J Clin Endocrinol Metab

Retrieve available abstracts of 37 articles:
HTML format



Single Articles


    December 2020
  1. NEWMAN CB, Blaha MJ, Boord JB, Cariou B, et al
    Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


    October 2020
  2. FERCHAUD-ROUCHER V, Zair Y, Aguesse A, Krempf M, et al
    Omega 3 Improves Both apoB100-containing Lipoprotein Turnover and their Sphingolipid Profile in Hypertriglyceridemia.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


    September 2020
  3. KOTWAL A, Cortes T, Genere N, Hamidi O, et al
    Treatment of Thyroid Dysfunction and Serum Lipids: A Systematic Review and Meta-Analysis.
    J Clin Endocrinol Metab. 2020 Sep 21. pii: 5909289. doi: 10.1210.
    PubMed     Abstract available


    May 2020
  4. KOZAKOVA M, Morizzo C, Penno G, Shore AC, et al
    Plasma Homocysteine and Cardiovascular Organ Damage in a Population with a High Prevalence of Risk Factors.
    J Clin Endocrinol Metab. 2020 May 26. pii: 5846189. doi: 10.1210.
    PubMed     Abstract available


    April 2020
  5. MORALES-PALOMO F, Ramirez-Jimenez M, Ortega JF, Moreno-Cabanas A, et al
    Exercise Training Adaptations in Metabolic Syndrome Individuals on Chronic Statin Treatment.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


  6. LANGSTED A, Jensen AMR, Varbo A, Nordestgaard BG, et al
    Low High-Density Lipoprotein Cholesterol to Monitor Long-Term Average Increased Triglycerides.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


    March 2020
  7. FANG S, Zhang S, Huang Y, Wu Y, et al
    Evidence for associations between Th1/Th17 "hybrid" phenotype and altered lipometabolism in very severe Graves' orbitopathy.
    J Clin Endocrinol Metab. 2020 Mar 16. pii: 5805506. doi: 10.1210.
    PubMed     Abstract available


  8. HSIUNG CN, Chang YC, Lin CW, Chang CW, et al
    The Causal Relationship of Circulating Triglyceride and Glycated Hemoglobin: A Mendelian Randomization Study.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


    January 2020
  9. KELSEY MM, Pyle L, Hilkin A, Severn CD, et al
    The impact of obesity on insulin sensitivity and secretion during pubertal progression: a longitudinal study.
    J Clin Endocrinol Metab. 2020 Jan 30. pii: 5717690. doi: 10.1210.
    PubMed     Abstract available


  10. SHAH VN, Bailey R, Wu M, Foster NC, et al
    Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry.
    J Clin Endocrinol Metab. 2020 Jan 19. pii: 5709622. doi: 10.1210.
    PubMed     Abstract available


    December 2019
  11. HIGGINS V, Omidi A, Tahmasebi H, Asgari S, et al
    Marked influence of adiposity on laboratory biomarkers in a healthy cohort of children and adolescents.
    J Clin Endocrinol Metab. 2019 Dec 17. pii: 5675353. doi: 10.1210.
    PubMed     Abstract available


  12. HIGGINS V, Asgari S, Hamilton JK, Wolska A, et al
    Postprandial dyslipidemia, hyperinsulinemia, and impaired gut peptides/bile acids in adolescents with obesity.
    J Clin Endocrinol Metab. 2019 Dec 11. pii: 5673404. doi: 10.1210.
    PubMed     Abstract available


    July 2019
  13. KAHKOSKA AR, Nguyen CT, Adair LA, Aiello AE, et al
    Longitudinal phenotypes of type 1 diabetes in youth based on weight and glycemia and their association with complications.
    J Clin Endocrinol Metab. 2019 Jul 10. pii: 5530245. doi: 10.1210/jc.2019-00734.
    PubMed     Abstract available


    June 2019
  14. VAN IERSEL L, Xu J, Potter B, Conklin HM, et al
    Clinical Importance of Free Thyroxine Concentration Decline after Radiotherapy for Pediatric and Adolescent Brain Tumors.
    J Clin Endocrinol Metab. 2019 Jun 7. pii: 5511532. doi: 10.1210/jc.2019-00539.
    PubMed     Abstract available


  15. MULLER-WIELAND D, Rader DJ, Moriarty PM, Bergeron J, et al
    Efficacy and Safety of Alirocumab 300 mg Every 4 Weeks in Individuals with Type 2 Diabetes on Maximally Tolerated Statin.
    J Clin Endocrinol Metab. 2019 Jun 5. pii: 5510497. doi: 10.1210/jc.2018-02703.
    PubMed     Abstract available


    May 2019
  16. LEROITH D, Biessels GJ, Braithwaite SS, Casanueva FF, et al
    Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline.
    J Clin Endocrinol Metab. 2019;104:1520-1574.
    PubMed     Abstract available


    February 2019
  17. LEE JY, Han K, Han E, Kim G, et al
    Risk of Incident Dementia According to Metabolic Health and Obesity Status in Late-life: a Population-based Cohort Study.
    J Clin Endocrinol Metab. 2019 Feb 25. pii: 5364430. doi: 10.1210/jc.2018-01491.
    PubMed     Abstract available


  18. SCHADE DS, Eaton RP
    A Simplified Approach to Reducing Cardiovascular Risk.
    J Clin Endocrinol Metab. 2019 Feb 20. pii: 5342943. doi: 10.1210/jc.2018-02509.
    PubMed     Abstract available


  19. BEHESHTI S, Madsen CM, Varbo A, Nordestgaard BG, et al
    How to identify familial premature myocardial infarction: comparing approaches to identify familial hypercholesterolemia.
    J Clin Endocrinol Metab. 2019 Feb 7. pii: 5307688. doi: 10.1210/jc.2018-02261.
    PubMed     Abstract available


    November 2018
  20. BIONDI B
    Peristent Dyslipidemia in Hypothyroid Patients: a Good Marker For Personalized Replacement Therapy?
    J Clin Endocrinol Metab. 2018 Nov 9. pii: 5167367. doi: 10.1210/jc.2018-02302.
    PubMed    


    August 2018
  21. OHNO Y, Sone M, Inagaki N, Yamasaki T, et al
    Obesity as a key factor underlying idiopathic hyperaldosteronism.
    J Clin Endocrinol Metab. 2018 Aug 24. pii: 5078439. doi: 10.1210/jc.2018-00866.
    PubMed     Abstract available


  22. EMANUELSSON F, Nordestgaard BG, Benn M
    Familial hypercholesterolemia and risk of peripheral arterial disease and chronic kidney disease.
    J Clin Endocrinol Metab. 2018 Aug 3. pii: 5063925. doi: 10.1210/jc.2018-01058.
    PubMed     Abstract available


  23. HALPERN B, Nery M, Pereira MAA
    Case Report of Acquired Generalized Lipodystrophy Associated With Common Variable Immunodeficiency.
    J Clin Endocrinol Metab. 2018;103:2807-2810.
    PubMed     Abstract available


    July 2018
  24. HIRAYAMA S, Nagasaka H, Honda A, Komatsu H, et al
    Cholesterol Metabolism Is Enhanced in the Liver and Brain of Children With Citrin Deficiency.
    J Clin Endocrinol Metab. 2018;103:2488-2497.
    PubMed     Abstract available


    June 2018
  25. PATNI N, Quittner C, Garg A
    Orlistat Therapy for Children With Type 1 Hyperlipoproteinemia: A Randomized Clinical Trial.
    J Clin Endocrinol Metab. 2018;103:2403-2407.
    PubMed     Abstract available


  26. WANG T, Zhao Z, Xu Y, Qi L, et al
    Insulin Resistance and beta-Cell Dysfunction in Relation to Cardiometabolic Risk Patterns.
    J Clin Endocrinol Metab. 2018;103:2207-2215.
    PubMed     Abstract available


    May 2018
  27. NICHOLS GA, Philip S, Reynolds K, Granowitz CB, et al
    Increased Cardiovascular Risk in Hypertriglyceridemic Patients with Statin-Controlled LDL Cholesterol.
    J Clin Endocrinol Metab. 2018 May 29. pii: 5005949. doi: 10.1210/jc.2018-00470.
    PubMed     Abstract available


    April 2018
  28. CHAN DC, Pang J, Hooper AJ, Bell DA, et al
    A Comparative Analysis of Phenotypic Predictors of Mutations in Familial Hypercholesterolemia.
    J Clin Endocrinol Metab. 2018;103:1704-1714.
    PubMed     Abstract available


    November 2017
  29. MARSCHE G, Zelzer S, Meinitzer A, Kern S, et al
    Adiponectin Predicts High-Density Lipoprotein Cholesterol Efflux Capacity in Adults Irrespective of Body Mass Index and Fat Distribution.
    J Clin Endocrinol Metab. 2017;102:4117-4123.
    PubMed     Abstract available


  30. KIM YH, Kim SM, Han KD, Son JW, et al
    Change in Weight and Body Mass Index Associated With All-Cause Mortality in Korea: A Nationwide Longitudinal Study.
    J Clin Endocrinol Metab. 2017;102:4041-4050.
    PubMed     Abstract available


    August 2017
  31. MINIC M, Rocha N, Harris J, Groeneveld MP, et al
    Constitutive Activation of AKT2 in Humans Leads to Hypoglycemia Without Fatty Liver or Metabolic Dyslipidemia.
    J Clin Endocrinol Metab. 2017;102:2914-2921.
    PubMed     Abstract available


    June 2017
  32. EIKELIS N, Lambert EA, Phillips S, Sari CI, et al
    Muscle Sympathetic Nerve Activity Is Associated With Elements of the Plasma Lipidomic Profile in Young Asian Adults.
    J Clin Endocrinol Metab. 2017;102:2059-2068.
    PubMed     Abstract available


    May 2017
  33. BROWN RJ, Meehan CA, Cochran E, Rother KI, et al
    Effects of Metreleptin in Pediatric Patients With Lipodystrophy.
    J Clin Endocrinol Metab. 2017;102:1511-1519.
    PubMed     Abstract available


  34. UEDA M, Dunbar RL, Wolska A, Sikora TU, et al
    A Novel APOC2 Missense Mutation Causing Apolipoprotein C-II Deficiency With Severe Triglyceridemia and Pancreatitis.
    J Clin Endocrinol Metab. 2017;102:1454-1457.
    PubMed     Abstract available


    February 2017
  35. HANNOUSH ZC, Puerta H, Bauer MS, Goldberg RB, et al
    New JAG1 Mutation Causing Alagille Syndrome Presenting With Severe Hypercholesterolemia: Case Report With Emphasis on Genetics and Lipid Abnormalities.
    J Clin Endocrinol Metab. 2017;102:350-353.
    PubMed     Abstract available


    June 2016
  36. CHANG PY, Gold EB, Cauley JA, Johnson WO, et al
    Triglyceride Levels and Fracture Risk in Midlife Women: Study of Women's Health Across the Nation (SWAN).
    J Clin Endocrinol Metab. 2016 Jun 13:jc20161366.
    PubMed     Abstract available


    May 2016
  37. ZAMRAZILOVA H, Weiss R, Hainer V, Aldhoon-Hainerova I, et al
    Cardiometabolic health in obese adolescents is related to length of obesity exposure: A pilot study.
    J Clin Endocrinol Metab. 2016 May 24:jc20161706.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dyslipidemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: